Reasonable design of the parameters of thermal processing such as conditioning and cooling according to formula changes of pelleted feeds has always been a serious challenge for Chinese feed mills and feed equipment m...Reasonable design of the parameters of thermal processing such as conditioning and cooling according to formula changes of pelleted feeds has always been a serious challenge for Chinese feed mills and feed equipment manufacturers. Studying the thermophysical properties of different protein feeds under different temperatures and particle sizes will facilitate the equipment design, parameter optimization, and simulation for the thermal processing of pelleted feeds. In this study, the specific heat (Cp), thermal conductivity (kb), and thermal diffusivity (α) of six plant protein supplements with three particle sizes were determined over a temperature range of 25℃-100℃. The differences in Cp, kb, and α among different feedstuffs and particle sizes were analyzed and the influences of temperature and particle size on these properties were evaluated. Results showed that the Cp, kb, and α of all the feedstuffs increased with increasing temperature and varied from 1.622 to 2.417 kJ/(kg∙℃), 0.080 to 0.362 W/(m∙℃), 6.379×10^(-8) to 21.984×10^(-8) m^(2)/s, respectively. To rise to the same temperature, the distiller’s dried grain with solubles (DDGS) needed to absorb 3% more heat than that required for soybean meal (SBM), while the rest four feedstuffs just needed to absorb 93%-98% heat for SBM. Particle size had no significant effect on Cp for all the feedstuffs (p>0.05). However, descending trends in kb and α were observed with increasing particle size for a certain feedstuff at the same bulk density. In addition, regression equations with only statistically significant terms were developed to describe Cp, kb, and α as a function of temperature and particle size for six feedstuffs. The results can provide basic theory and data for the optimization of thermal processing parameters required for the plant-protein ingredient change in compound feed formulations.展开更多
Background: Lipid-lowering effect ofRhus coriaria L. (Rhus) has been investigated in multiple animal stud- ies with promising results. Nonetheless, its clinical efficacy has not been adequately examined. Objective...Background: Lipid-lowering effect ofRhus coriaria L. (Rhus) has been investigated in multiple animal stud- ies with promising results. Nonetheless, its clinical efficacy has not been adequately examined. Objective: The aim of this study was to evaluate the lipid-lowering effects of Rhus among patients with hyperlipidemia. Design, setting, participants and interventions: The study was designed as a two-arm, double-blind placebo-controlled randomized clinical trial, using a parallel design. Eighty patients with primary hyper- lipidemia were randomly assigned to receive Rhus capsules or placebo for 6 weeks. Main outcome measures: The serum lipid levels, apolipoprotein-A1 (Apo-A1) and apolipoprotein-B (Apo-B) were measured. Results: Mean serum high-density lipoprotein cholesterol (HDL-C) and Apo-Al levels were significantly increased in the Rhus group, compared with the placebo group, after 6 weeks of intervention (P= 0.001). The analysis of covariance test including age, gender, body mass index (BMI), and smoking as co-variables revealed that the increase in HDL-C and Apo-A1 levels remained significant, and increases in HDL-C were dependent on the increase in Apo-A1 levels. No significant difference was observed between Rhus and placebo groups in terms of mean reductions in total cholesterol, low-density lipopro- tein cholesterol and triglyceride levels; however, more significant improvement was observed among obese patients (BMI≥ 30 kg/m^2). Conclusion: The study showed significant increases in HDL-C and Apo-Al levels in response to Rhus sup- plementation in patients with hyperlipidemia. Trial registration: ClinicalTrials.gov ID: NCT02295293.展开更多
基金supported by the International S&T Cooperation Program of China (Grant No.2019YFE0103800).
文摘Reasonable design of the parameters of thermal processing such as conditioning and cooling according to formula changes of pelleted feeds has always been a serious challenge for Chinese feed mills and feed equipment manufacturers. Studying the thermophysical properties of different protein feeds under different temperatures and particle sizes will facilitate the equipment design, parameter optimization, and simulation for the thermal processing of pelleted feeds. In this study, the specific heat (Cp), thermal conductivity (kb), and thermal diffusivity (α) of six plant protein supplements with three particle sizes were determined over a temperature range of 25℃-100℃. The differences in Cp, kb, and α among different feedstuffs and particle sizes were analyzed and the influences of temperature and particle size on these properties were evaluated. Results showed that the Cp, kb, and α of all the feedstuffs increased with increasing temperature and varied from 1.622 to 2.417 kJ/(kg∙℃), 0.080 to 0.362 W/(m∙℃), 6.379×10^(-8) to 21.984×10^(-8) m^(2)/s, respectively. To rise to the same temperature, the distiller’s dried grain with solubles (DDGS) needed to absorb 3% more heat than that required for soybean meal (SBM), while the rest four feedstuffs just needed to absorb 93%-98% heat for SBM. Particle size had no significant effect on Cp for all the feedstuffs (p>0.05). However, descending trends in kb and α were observed with increasing particle size for a certain feedstuff at the same bulk density. In addition, regression equations with only statistically significant terms were developed to describe Cp, kb, and α as a function of temperature and particle size for six feedstuffs. The results can provide basic theory and data for the optimization of thermal processing parameters required for the plant-protein ingredient change in compound feed formulations.
基金supported by a grant from Shiraz University of Medical Sciences–Iran (Grant No. 92-5581)
文摘Background: Lipid-lowering effect ofRhus coriaria L. (Rhus) has been investigated in multiple animal stud- ies with promising results. Nonetheless, its clinical efficacy has not been adequately examined. Objective: The aim of this study was to evaluate the lipid-lowering effects of Rhus among patients with hyperlipidemia. Design, setting, participants and interventions: The study was designed as a two-arm, double-blind placebo-controlled randomized clinical trial, using a parallel design. Eighty patients with primary hyper- lipidemia were randomly assigned to receive Rhus capsules or placebo for 6 weeks. Main outcome measures: The serum lipid levels, apolipoprotein-A1 (Apo-A1) and apolipoprotein-B (Apo-B) were measured. Results: Mean serum high-density lipoprotein cholesterol (HDL-C) and Apo-Al levels were significantly increased in the Rhus group, compared with the placebo group, after 6 weeks of intervention (P= 0.001). The analysis of covariance test including age, gender, body mass index (BMI), and smoking as co-variables revealed that the increase in HDL-C and Apo-A1 levels remained significant, and increases in HDL-C were dependent on the increase in Apo-A1 levels. No significant difference was observed between Rhus and placebo groups in terms of mean reductions in total cholesterol, low-density lipopro- tein cholesterol and triglyceride levels; however, more significant improvement was observed among obese patients (BMI≥ 30 kg/m^2). Conclusion: The study showed significant increases in HDL-C and Apo-Al levels in response to Rhus sup- plementation in patients with hyperlipidemia. Trial registration: ClinicalTrials.gov ID: NCT02295293.